EX-99.1 2 ea189157ex99-1_theratech.htm JOINT FILING AGREEMENT, DATED NOVEMBER 28, 2023, AMONG THE REPORTING PERSONS

EXHIBIT 1

 

JOINT FILING AGREEMENT

 

In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock of the Issuer and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. It is understood and agreed that each of the persons named below is responsible for the timely filing of such statement and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein, but such person is not responsible for the completeness or accuracy of information concerning the other person(s) unless such person knows or has reason to believe that such information is inaccurate.

 

Date: November 28, 2023

 

  SOLEUS CAPITAL MASTER FUND, L.P.
     
  By: Soleus Capital, LLC,
    Its General Partner
     
  By: Soleus Capital Group, LLC,
    Its Managing Member
     
  By: /s/ Guy Levy
  Name: Guy Levy
  Title: Managing Member
     
  SOLEUS CAPITAL, LLC
     
  By: Soleus Capital Group, LLC,
    Its Managing Member
     
  By: /s/ Guy Levy
  Name: Guy Levy
  Title: Managing Member
     
  SOLEUS CAPITAL GROUP, LLC
     
  By: /s/ Guy Levy
  Name:  Guy Levy
  Title: Managing Member
     
  /s/ Guy Levy
  Guy Levy